Trending

Aurobindo Pharma gains after American subsidiary inks product development pact with global pharma major

Image

Aurobindo Pharma added 1.44% to Rs 1241.30 after the company's wholly owned subsidiary Aurobindo Pharma USA Inc entered into a collaboration and license agreement with a global pharma major.

You Might Also Like...

Sign Up for Our Newsletter

Subscribe now to get notified about exclusive offers
from The .... every week!